{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:00:48Z","timestamp":1780574448106,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.07.090","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T18:24:18Z","timestamp":1438712658000},"page":"5313-5315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Profiling the host immune response to tuberculosis vaccines"],"prefix":"10.1016","volume":"33","author":[{"given":"Helen A.","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0135","first-page":"71","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization. 1991","volume":"79","author":"Kochi","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.vaccine.2015.07.090_bib0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.07.090_bib0145","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1472-9792(12)70005-7","article-title":"Tuberculosis vaccines: a strategic blueprint for the next decade","volume":"92","author":"Brennan","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2015.07.090_bib0150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.vaccine.2015.07.090_bib0155","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.vaccine.2015.07.090_bib0160","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal Bacille Calmette\u2013Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"issue":"9451","key":"10.1016\/j.vaccine.2015.07.090_bib0165","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"issue":"5368","key":"10.1016\/j.vaccine.2015.07.090_bib0170","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.280.5368.1432","article-title":"Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency","volume":"280","author":"Altare","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.090_bib0175","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/340510","article-title":"Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis Bacille Calmette\u2013Guerin infection","volume":"185","author":"Elloumi-Zghal","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.090_bib0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/338625","article-title":"Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds","volume":"70","author":"Picard","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"5368","key":"10.1016\/j.vaccine.2015.07.090_bib0185","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.280.5368.1435","article-title":"Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients","volume":"280","author":"de Jong","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/immu.200390008","article-title":"Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency","volume":"33","author":"Lichtenauer-Kaligis","year":"2003","journal-title":"Eur J Immunol"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2015.07.090_bib0195","article-title":"Clinical immunology and multiplex biomarkers of human tuberculosis","volume":"5","author":"Walzl","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7309","key":"10.1016\/j.vaccine.2015.07.090_bib0200","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/gene.2010.51","article-title":"Human gene expression profiles of susceptibility and resistance in tuberculosis","volume":"12","author":"Maertzdorf","year":"2011","journal-title":"Genes Immun"},{"issue":"9871","key":"10.1016\/j.vaccine.2015.07.090_bib0215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.090_bib0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2334-14-314","article-title":"Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response","volume":"14","author":"Matsumiya","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2015.07.090_bib0230","doi-asserted-by":"crossref","first-page":"e67922","DOI":"10.1371\/journal.pone.0067922","article-title":"Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A","volume":"8","author":"Matsumiya","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.07.090_bib0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-8794-2-10","article-title":"Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth","volume":"2","author":"Fletcher","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0240","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1186\/s12879-014-0660-7","article-title":"Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A","volume":"14","author":"Tanner","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.090_bib0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.07.090_bib0250","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/infdis\/jit647","article-title":"Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine: MVA85A, alone and in combination","volume":"209","author":"Harris","year":"2014","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2015.07.090_bib0255","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/jis012","article-title":"A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis Bacille Calmette\u2013Guerin","volume":"205","author":"Minassian","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.090_bib0260","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/infdis\/jiu615","article-title":"Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model","volume":"21","author":"Matsumiya","year":"2015","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T22:18:41Z","timestamp":1567030721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15010683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15010683"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling the host immune response to tuberculosis vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}